Pulmonary Rehabilitation Is Associated With Decreased Exacerbation and Mortality in Patients With COPD

医学 恶化 慢性阻塞性肺病 死亡率 肺康复 康复 入射(几何) 间接成本 慢性阻塞性肺病加重期 医疗费用 医疗保健 内科学 急诊医学 重症监护医学 物理疗法 慢性阻塞性肺疾病急性加重期 会计 光学 物理 业务 经济增长 经济
作者
Joon Young Choi,Ki Uk Kim,Deog Kyeom Kim,Yu‐Il Kim,Tae‐Hyung Kim,Won‐Yeon Lee,Seoung Ju Park,Yong Bum Park,Jin Woo Song,Kyeong‐Cheol Shin,Soo‐Jung Um,Kwang Ha Yoo,Hyoung Kyu Yoon,Chang Youl Lee,Ho Sung Lee,Ah Young Leem,Won-Il Choi,Seong Yong Lim,Chin Kook Rhee
出处
期刊:Chest [Elsevier BV]
卷期号:165 (2): 313-322 被引量:8
标识
DOI:10.1016/j.chest.2023.09.026
摘要

Background

Poor uptake to pulmonary rehabilitation (PR) is still challenging around the world. There have been few nationwide studies investigating whether PR impacts patient outcomes in COPD. We investigated the change of annual PR implementation rate, medical costs, and COPD outcomes including exacerbation rates and mortality between 2015 and 2019.

Research Question

Does PR implementation improve outcomes in patients with COPD in terms of direct cost, exacerbation, and mortality?

Study Design and Methods

Data of patients with COPD extracted from a large Korean Health Insurance Review and Assessment service database (2015-2019) were analyzed to determine the trends of annual PR implementation rate and direct medical costs of PR. Comparison of COPD exacerbation rates between pre-PR and post-PR, and the time to first exacerbation and mortality rate according to PR implementation, were also assessed.

Results

Among all patients with COPD in South Korea, only 1.43% received PR. However, the annual PR implementation rate gradually increased from 0.03% to 1.4% during 4 years, especially after health insurance coverage commencement. The direct medical cost was significantly higher in the PR group than the non-PR group, but the costs in these groups showed decreasing and increasing trends, respectively. Both the incidence rate and frequency of moderate-to-severe and severe exacerbations were lower during the post-PR period compared with the pre-PR period. The time to the first moderate-to-severe and severe exacerbations was longer in the PR group than the non-PR group. Finally, PR implementation was associated with a significant decrease in mortality.

Interpretation

We concluded that health insurance coverage increases PR implementation rates. Moreover, PR contributes toward improving outcomes including reducing exacerbation and mortality in patients with COPD. However, despite the well-established benefits of PR, its implementation rate remains suboptimal.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
量子星尘发布了新的文献求助10
1秒前
XH发布了新的文献求助10
1秒前
1秒前
2秒前
liao发布了新的文献求助10
3秒前
KM完成签到,获得积分10
3秒前
深情安青应助喜悦的梦芝采纳,获得30
4秒前
冷傲天川发布了新的文献求助10
4秒前
ganymede发布了新的文献求助10
4秒前
5秒前
o耶好困完成签到,获得积分10
5秒前
洁净艳一发布了新的文献求助10
5秒前
6秒前
m30完成签到,获得积分10
6秒前
Xiaohu完成签到,获得积分10
6秒前
7秒前
格格星发布了新的文献求助10
7秒前
风中小夏发布了新的文献求助10
7秒前
李健应助秀丽早晨采纳,获得10
8秒前
和谐的颜完成签到,获得积分10
8秒前
plain完成签到,获得积分10
8秒前
JamesPei应助魔幻冷梅采纳,获得10
9秒前
莫里亚蒂发布了新的文献求助10
9秒前
脑洞疼应助钟沐晨采纳,获得10
9秒前
科研通AI6应助nnnnnnxh采纳,获得10
9秒前
一个要饭界的大佬完成签到,获得积分10
9秒前
梁云发布了新的文献求助10
10秒前
10秒前
科研通AI6应助典雅的俊驰采纳,获得10
11秒前
孙友浩发布了新的文献求助10
11秒前
小陈老板完成签到 ,获得积分10
11秒前
Tim发布了新的文献求助10
11秒前
小二郎应助洁净艳一采纳,获得10
11秒前
Rubby应助我爱科研采纳,获得30
12秒前
12秒前
量子星尘发布了新的文献求助10
12秒前
浮浮世世应助年轻豌豆采纳,获得50
13秒前
13秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Feigin and Cherry's Textbook of Pediatric Infectious Diseases Ninth Edition 2024 4000
Einführung in die Rechtsphilosophie und Rechtstheorie der Gegenwart 1500
Cowries - A Guide to the Gastropod Family Cypraeidae 1200
青少年心理适应性量表(APAS)使用手册 700
Air Transportation A Global Management Perspective 9th Edition 700
Socialization In The Context Of The Family: Parent-Child Interaction 600
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5005236
求助须知:如何正确求助?哪些是违规求助? 4248931
关于积分的说明 13239041
捐赠科研通 4048486
什么是DOI,文献DOI怎么找? 2214899
邀请新用户注册赠送积分活动 1224821
关于科研通互助平台的介绍 1145241